GW Pharma stock jumps to record after DEA stance on its CBD drug, cannabis sector lags
September 27, 2018 at 12:36 PM EDT
Shares of GW Pharmaceuticals PLC surged to a record high Thursday, after the medical-marijuana company announced a new Drug Enforcement Administration stance on its approved drug containing cannabidiol, or CBD.